氟代脱氧葡萄糖正电子发射断层扫描（FDG PET）在淋巴瘤管理中的作用：证据基础是什么？

The role of FDG PET in the management of lymphoma: what is the evidence base?

作者信息

Kirby Anna M, Mikhaeel N George

机构信息

Department of Clinical Oncology, Guy's and St Thomas' NHS Trust, London, UK.

出版信息

Nucl Med Commun. 2007 May;28(5):335-54. doi: 10.1097/MNM.0b013e3280895e23.

DOI:10.1097/MNM.0b013e3280895e23

PMID:17414883

Abstract

[18F]Fluorodeoxyglucose positron emission tomography (18F-FDG PET) is playing an increasing role in the management of both Hodgkin and non-Hodgkin lymphoma, offering potential advantages in the accuracy of disease assessment at a number of points in the management pathway. This review evaluates the current level of confidence in the use of PET technology in (1) initial staging, (2) the assessment of early response to chemotherapy, (3) the assessment of residual masses at completion of initial treatment, (4) follow-up, and (5) radiotherapy planning.

摘要

[18F]氟脱氧葡萄糖正电子发射断层扫描（18F-FDG PET）在霍奇金淋巴瘤和非霍奇金淋巴瘤的治疗中发挥着越来越重要的作用，在治疗过程中的多个环节的疾病评估准确性方面具有潜在优势。本综述评估了目前对PET技术在以下方面应用的信心水平：（1）初始分期；（2）化疗早期反应评估；（3）初始治疗完成时残余肿块评估；（4）随访；（5）放射治疗计划。